1. The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cells

   • Takehiro Yamagishi
   • Shiro Nakaike
   • Shigeru Tsukagoshi

   Original Articles Pages: 249 - 254

2. Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer

   • M. Guillaume Wientjes
   • Robert A. Badalament
   • Jessie L -S. Au

   Original Articles Pages: 255 - 262

3. Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture

   • Jun-Ichi Yamamoto
   • Yashuharu Nagai
   • Shoji Awazu

   Original Articles Pages: 263 - 267

4. Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis

   • Steven M. Grunberg
   • Montague Lane
   • Polly E. Sanderson

   Original Articles Pages: 268 - 272

5. Disposition of total and unbound etoposide following high-dose therapy

   • Terry L. Schwinghammer
   • Ronald A. Fleming
   • Clinton F. Stewart

   Original Articles Pages: 273 - 278

6. Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line

   • Eizo Kimura
   • Robert E. Enns
   • Stephen B. Howell

   Original Articles Pages: 279 - 285

7. Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography

   • Olaf van Tellingen
   • Jos H. Beijnen
   • Auke Bult

   Original Articles Pages: 286 - 292

8. Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines

   • Hideki Morimoto
   • Paola Princine
   • Benjamin Bonavida

   Original Articles Pages: 293 - 300

9. Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study

   • Carlo M. Camaggi
   • Elena Strocchi
   • Franco Pannuti

   Original Articles Pages: 301 - 309

10. Pharmacokinetics of PEG-l-asparaginase and plasma and cerebrospinal fluidl-asparagine concentrations in the rhesus monkey

    • Stacey L. Berg
    • Frank M. Balis
    • David G. Poplack

    Original Articles Pages: 310 - 314

11. Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors

    • Beverly A. Teicher
    • Devasis Chatterjee
    • Gulshan Ara

    Original Articles Pages: 315 - 319

12. Tumour profile ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouse

    • James W. Paxton
    • Debbie Young
    • Philip Kestell

    Short Communication Pages: 320 - 322

13. Pharmacokinetics of acridine-4-carboxamide in the rat, with extrapolation to humans

    • James W. Paxton
    • Deborah Young
    • Iain G. G. Robertson

    Short Communication Pages: 323 - 325

14. Development and initial characterization of a mitomycin C-resistant colon cancer cell line variant

    • Roger R. Perry
    • Bridget R. Greaves
    • Yuan Kang

    Short Communication Pages: 326 - 328

15. Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinoma

    • Christine Lassel
    • Yacine Merrouche
    • Thierry Philip

    Short Communication Pages: 329 - 331